Thalassaemia drug, Ferriprox

Thalassaemia drug, Ferriprox

M625/1585 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 36.4MB

Downloadable file size: 1.6MB

Price image Pricing

Please login to use the price calculator


Credit: MAURO FERMARIELLO/SCIENCE PHOTO LIBRARY

Caption: Thalassaemia drug. Pills of the chelating agent Ferriprox (deferiprone). A chelating agent removes heavy metals. In this case it removes excess iron from the blood. This is a common condition in patients who have to undergo regular blood transfusions, for example patients with thalassaemia. Thalassaemia is an inherited condition where the red blood cells are fragile and easily damaged. There has been controversy over the side-effects of deferiprone, and as of 2007 it is licensed for use in Europe and Asia, but not the USA or Canada.

Release details: Model release not required. Property release not required.

Keywords: 21st century, biochemical, biochemistry, blood, caplet, caplets, chelating agent, controversial, deferiprone, drug, duo, europe, european, excess, ferriprox, haematology, healthcare, heavy metal, hematology, inorganic chemistry, iron, italian, italy, medical, medicine, pair, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, poisoning, removing, still life, still-life, tablet, tablets, thalassaemia, thalassemia, toxicity, transfusions, treatment, two

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.